hemi-actinomycin IV. 3-HA: 3-hydroxyanthranilic acid, 4-MHA: 4-methyl-3-hydroxyanthranilic acid, Acm: actinomycin. Separation was on silica thin-layer plates using solvent system I. Time of exposure of the chromatogram to x-ray film was 3 d. Figure S4 : MALDI-TOF mass spectra of mono-and di-C-demethyl-hemi-actinomycin IV. - Figure S7 : Antimicrobial activity of Hemi-actinomycin IV against Bacillus subtillis. Plate diffusion tests were performed as described in Material and Methods. Shown are in vivo inhibitory activity of hemi-actinomycin IV and actinomycin IV against B. subtillis. The indicated amounts of compounds dissolved in ethanol were spotted on paper discs (6 mm diameter, Schleicher and Schuell) and after drying were laid on a soft top nutrient agar (Difco) inoculated with 0.1 % (v/v) of an overnight culture of Bacillus subtilis ATCC 6633. After incubation at 30 °C over night a diameter of inhibition zones were determined. Table S1 : The numbers set in parenthesis behind the masses of hemi-actinomycin Dfragments correspond to the numbers indicating prominent mass peaks in the corresponding PSD-MALDI-TOF mass spectra shown in Figure S5 .
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